Emerging Agents in the Pipeline for Merkel Cell Carcinoma
2 Visninger
administrator
07/17/23
Howard L. Kaufman, MD, FACS, chief surgical officer and associate director for clinical science at Rutgers Cancer Institute of New Jersey, discusses emerging agents in the pipeline for Merkel cell carcinoma.
Vis mere
Facebook kommentarer
Ingen kommentarer fundet